Intrusion Puts Hard Numbers on the VigilAigent Deal in Fresh Shareholder Push

summarizeSummary

Intrusion's latest shareholder campaign quantifies the VigilAigent deal for the first time, revealing ~$3.5M in ARR, ~1,000 customers, and $3M+ in cost synergies, while cautioning that a failed vote on Proposal 3 could force renegotiation or cash outlays.

check_boxKey Events · M&A and Partnerships · INTZ

• Deal Economics Quantified

  A fact sheet finally puts hard numbers on the acquisition: VigilAigent contributes roughly $3.5M in annual recurring revenue, about 1,000 customers, more than 80 reseller partners, and over $3M in identified annualized cost synergies.

• Voting Disqualification Disclosed

  Under Nasdaq rules, the 2,223,549 shares issued to VigilAigent at the June 29 First Closing cannot be voted on Proposal 3, a restriction that could shift the approval threshold.

• Failure Consequences Spelled Out

  Should Proposal 3 fail, Intrusion would be unable to issue shares beyond the 19.9% Nasdaq cap, potentially forcing a renegotiation of the Second Closing or Earn-Out, a draw on cash reserves, or pursuit of alternative financing — a material risk given the company's going-concern status.

• Early Execution Metrics

  Within roughly three weeks of closing, over $350K in annualized new business and renewals were secured, including a top-partner renewal with a total contract value exceeding $300K and new MSP partners each carrying more than $1M in ARR potential.

auto_awesomeAnalysis · INTZ · Technology

For the first time, Intrusion's new proxy solicitation materials attach concrete figures to the VigilAigent acquisition — roughly $3.5M in annual recurring revenue, about 1,000 customers, and over $3M in identified cost synergies — while also disclosing that 2.2M shares already issued to the seller are barred from voting on the pivotal Proposal 3. The FAQ warns that a failed vote could trigger renegotiation or cash outlays, heightening the stakes for the August 27 meeting. Against a backdrop of a going-concern warning, a 50% revenue drop, and a NASDAQ delisting notice, these details equip shareholders with tangible metrics to assess whether the deal truly fortifies the company or merely adds complexity.